Top Markets
#1 Cortex Cortex +173.67%
#2 GEKKO GEKKO +53.94%
#3 Helium Helium +32.96%
#4 Audiera Audiera +20.48%
#5 ADO Protocol ADO Protocol +17.96%
#6 Ontology Gas Ontology Gas +15.92%
#7 Pons Pons +15.26%
#8 COTI COTI +14.32%
#9 o1.exchange o1.exchange +13.62%
#10 TENDIES TENDIES +9.27%
Coin of the day
Cortex Cortex
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Kedudukan dalam Saham #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Harga Saham
$59.98
Disegerakkan terakhir: 2024-12-13
Modal Pasaran
$1.22B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Longboard Pharmaceuticals, Inc. (LBPH)

Kategori

Healthcare
Hasil untuk Longboard Pharmaceuticals, Inc. (LBPH)
Hasil pada Sep 2024 TTM: $8.00K
Menurut laporan kewangan terkini daripada Longboard Pharmaceuticals, Inc., hasil semasa syarikat (TTM) ialah $8.00K. Pada tahun 2022, syarikat memperoleh hasil sebanyak 0.00 sama dengan hasil pada tahun 2021 iaitu 0.00. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Longboard Pharmaceuticals, Inc. dari 2020 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
2026 (TTM) $8.00K 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 157,803,650.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 75,265,991.36%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B 196,803,989.28%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B 27,849,900.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH